Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
28.01
-0.17 (-0.60%)
Official Closing Price
Updated: 7:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
32
33
Next >
Atopic Dermatitis Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies, Patient Pool, and Companies DelveInsight | Sanofi, Regeneron, Pfizer, Japan Tobacco, Torii Pharmaceutical
June 20, 2023
Via
AB Newswire
Exposures
Product Safety
Alopecia Areata Market Analysis, Growth Opportunities, Clinical Trials Assessment, Emerging Therapies, Leading Companies, and Epidemiology Forecast | Arcutis, Concert Pharmaceutical, HCW Biologics
June 20, 2023
Via
AB Newswire
Biologics and Biosimilars Market Is Touching New Level – A Comprehensive Study with Key Players Amgen, AbbVie, Sanofi-Aventis
June 19, 2023
Biologics and Biosimilar Market Size, Status and Forecast 2028
Via
SBWire
Topics
Intellectual Property
Exposures
Intellectual Property
ABSSSI Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies and Market Forecast by DelveInsight| Merck, Pfizer, Paratek Pharmaceutical, Melinta Therapeutics, Allergan, Novexel
June 16, 2023
Via
AB Newswire
Exposures
Product Safety
Onycholysis Market expected to rise | Companies – NexMed, Pfizer, expected to drive market
June 13, 2023
Via
AB Newswire
Complicated Urinary Tract Infection (cUTI) Market to Witness Growth by 2032, Estimates DelveInsight| Meiji Seika Pharma, Pfizer, Novartis, Spero Therapeutics, Tetraphase Pharmaceuticals, Wockhardt
June 16, 2023
Via
AB Newswire
Postherpetic Neuralgia Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest Drug Approvals by DelveInsight | Pfizer, Winston Laboratories, Xenon Pharma, Bausch Health, Shanghai SIMR
June 16, 2023
Via
AB Newswire
Neuroendocrine Tumors Pipeline, Clinical Trials, and Emerging Drugs (2023) | Companies – MedImmune, Genentech, Merck & Co, Pfizer, Takeda Oncology, Hutchison MediPharma, and Others
June 16, 2023
Via
AB Newswire
Bullish or Bearish? Vetting Animal Health Care Stocks
June 16, 2023
Americans are paying more and more attention to pet health, making pet care stocks look healthy again. Here are two names worth a check up.
Via
MarketBeat
Topics
ETFs
Oligodendroglioma Market expected to rise | Companies – EpicentRx, Pfizer, Oblato, Istari Oncology, Bayer, Chimerix, Pfizer, Abbott, expected to drive market
June 15, 2023
Via
AB Newswire
Oncocytoma Market expected to rise | Companies- Pfizer, AstraZeneca, Bristol-Myers Squibb Company, expected to drive market
June 15, 2023
Via
AB Newswire
Ischemic Stroke Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies and Market Forecast by DelveInsight | Roche, Boehringer Ingelheim, Bayer AG, Pfizer, Biogen, Daiichi Sankyo
June 15, 2023
Via
AB Newswire
Exposures
Product Safety
Obesity Pipeline Report, 2023 Updates: In-depth Analysis into the Clinical Trials, Latest Drug Approvals, Emerging Drugs, and Growth Prospects | Innovent, Pfizer, Boehringer Ingelheim, Eli Lilly
June 15, 2023
Via
AB Newswire
Neurofibrosarcoma Pipeline 2023: Mapping the Path to Improved Patient Outcomes | Companies – Astex Pharmaceuticals, Ascentage Pharma Group, Apexigen, Nobelpharma, Pfizer, and Others
June 15, 2023
Via
AB Newswire
Contract Development and Manufacturing Organization (CDMO) Market Size to Surpass USD 143 Billion by 2028, States DelveInsight | Patheon, Thermo Fisher Scientific, Catalent, Merck, Pfizer, Lonza
June 14, 2023
Via
AB Newswire
Ocular Melanoma Market expected to rise | Companies – Eli Lilly & Co, Spectrum Pharmaceuticals Inc, Novartis AG, Bayer, AstraZeneca plc, Merck, Amgen, Pfizer Inc, Roche, expected to drive market
June 14, 2023
Via
AB Newswire
Focal Segmental Glomerulosclerosis Pipeline, Clinical Trials, and Emerging Therapies (2023) | Companies – Dimerix Bioscience, Travere Therapeutics, Horizon Therapeutics, Pfizer, and Others
June 14, 2023
Via
AB Newswire
Filariasis Market and Epidemiology 2032: Treatment Market, Therapies, FDA Approvals, and Companies by DelveInsight | Johnson & Johnson, Pfizer, Eisai Co Ltd, Atra Pharmaceuticals, AbbVie, Novartis
June 14, 2023
Via
AB Newswire
Exposures
Product Safety
Onychomycosis Market expected to rise | Companies – Moberg Pharma, Blueberry Therapeutics, Hallux, Pfizer, Bausch Health, Sato Pharmaceutical, Eisai, expected to drive market
June 13, 2023
Via
AB Newswire
Hemophilia B Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest Drug Approvals by DelveInsight | Pfizer, Spark Therapeutics, Sanofi, Alnylam Pharma, CSL Behring, uniQure, Novo Nordisk
June 13, 2023
Via
AB Newswire
Bone Neoplasms Clinical Trials | A Drug Pipeline Analysis Report 2023 | Companies – Amgen, Novartis, Roche, Merck, Luye Pharma, Bayer, Pfizer.
June 12, 2023
Via
AB Newswire
Opioid Overdose Market expected to rise | Companies – Purdue Pharmaceuticals L.P., Titan Pharmaceuticals, Inc., Pfizer Inc., Mallinckrodt, Pfizer Inc., Assertio Holdings, expected to boost the market
June 12, 2023
Via
AB Newswire
Vitamin B12 Market May Set Massive Growth by 2030
June 09, 2023
Get an extensive Vitamin B12 Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.
Via
SBWire
2022 R&D Spending and Intensity Benchmarks
June 12, 2023
VIRGINIA BEACH, Va. - June 12, 2023 - PRLog -- According to a newly released study from Schonfeld & Associates, Inc., R&D Ratios & Budgets, the pharmaceutical industry continued to be the biggest R&D...
Via
PRLog
Topics
Supply Chain
Exposures
Supply Chain
Veterinary Healthcare Product Market to See Huge Growth : Pfizer, Merck, Johnson & Johnson
June 06, 2023
Stay up-to-date with Veterinary Healthcare Product Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
June 06, 2023
From
Pfizer Inc.
Via
Business Wire
Phase 3 Studies of Pfizer’s Novel Antibiotic Combination Offer New Treatment Hope for Patients with Multidrug-Resistant Infections and Limited Treatment Options
June 01, 2023
From
Pfizer Inc.
Via
Business Wire
Is CXApp Inc.an AI Contender or Pretender?
June 01, 2023
CXApp Inc. (NASDAQ: CXAI) shares have been caught up in the artificial intelligence (AI) mania. On no news, its shares spiked to $21 on April 23, 2023, and have
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults
May 31, 2023
From
Pfizer Inc.
Via
Business Wire
3 Stocks Worth Buying at 52-Week Lows
May 30, 2023
Here are three stocks that are trading near their 52-week lows and may be primed for a short-term rally for opportunistic investors
Via
MarketBeat
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.